The Ritedose Corporation, a South Carolina-based pharmaceutical manufacturer specialising in Blow-Fill-Seal (BFS) technology, on Wednesday unveiled its new distribution and logistics facility at Performance Park.
At the heart of Performance Park is a new 225,000-square-foot central distribution and logistics centre that is claimed to expand Ritedose's capabilities to handle well over 2 billion doses per year. The new facility is part of a multiphase USD81m investment that has created an additional 100 new jobs.
"This purpose-built facility marks the next phase of growth for Ritedose Performance Park," said Ritedose CEO Jody Chastain. "It expands our capabilities to handle logistics and distributions of well over 2 billion doses per year. However, we weren't just thinking about growing square footage, labs or equipment when we started planning this facility -- our thoughts were also on growing our people and supporting our community. We're a different kind of company that is deeply rooted in our purpose and driven by passion to make a difference in the lives of others, and we're just getting started."
Harbour BioMed and Otsuka collaborate on advancing BCMAxCD3 bispecific T-cell engagers
FDA approves Dupixent as first targeted therapy for rare skin disease bullous pemphigoid
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement
Dizal completes enrolment in sunvozertinib vs. platinum doublet phase III study
Oxurion signs LOI to acquire majority stake in preclinical microbiology CRO
Ritedose unveils new distribution and logistics facility
IMUNON unveils promising Phase 2 translational data for IMNN-001 in advanced ovarian cancer